Quercetin protection against ciprofloxacin induced liver damage in rats

Biotechnic and Histochemistry

Volumn 91, Issue 2, 2016, Pages 116-121

  Taslidere, E ^a   Dogan, Z ^b   Elbe, H ^c   Vardi, N ^d   Cetin, A ^d   Turkoz, Y ^d  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

^c MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^d INONU UNIVERSITY   (Turkey)

Author keywords

ciprofl oxacin; liver; quercetin; rat

Indexed keywords

ANTIOXIDANT; CIPROFLOXACIN; QUERCETIN;

ANIMAL; CELL PROTECTION; CHEMICAL AND DRUG INDUCED LIVER INJURY; DISEASE MODEL; DRUG EFFECTS; FEMALE; OXIDATIVE STRESS; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; CIPROFLOXACIN; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FEMALE; OXIDATIVE STRESS; QUERCETIN; RATS, WISTAR;

EID: 84955346733     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2015.1085093     Document Type: Article

References (31)

1. Adikwu E, Brambaifa N (2012) Ciprofloxacin cardiotoxicity and hepatotoxicity in humans and animals. Pharmacol. Pharm. 3: 207-213.
2. Andrade RJ, Tulkens PM (2011) Hepatic safety of antibiotics used in primary care. J. Antimicrob. Chemother. 66: 1431-1446.
3. Andrade RJ, Lucena MI, Fernández MC, Pelaez G, Pachkoria K, García-Ruiz E, García-Muñoz B, González-Grande R, Pizarro A, Durán JA, Jiménez M, Rodrigo L, Romero-Gomez M, Navarro JM, Planas R, Costa J, Borras A, Soler A, Salmerón J, Martin-Vivaldi R: Spanish Group for the Study of Drug-Induced Liver Disease (2005) Drug induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129: 512-521.
4. Bataille L, Rahier J, Geubel A (2002) Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn's disease. J. Hepatol. 37: 696-699.
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
6. Channa MA, Janjua MZJ (2003) Effects of ciprofloxacin on foetal hepatocytes. Pak. Med. Assoc. 53: 448-450.
7. Chirumbolo S (2010) The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflam. Aller. Drug Targ. 9: 263-285.
8. Cuevas MJ, Tieppo J, Marroni NP, Tuñón MJ, González-Gallego J (2011) Suppression of amphiregulin/epidermal growth factor receptor signals contributes to the protective effects of quercetin in cirrhotic rats. J. Nutr. 141: 1299-1305.
9. Desarro A, Desarro G (2001) Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr. Med. Chem. 8: 371-384.
10. Dichiara AJ, Atkinson M, Goodman Z, Sherman KE (2008) Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva Gastroenterol. Dietol. 54: 307-315.
11. Dossing M, Sonne J (1993) Drug-induced hepatic disorders. Incidence, management and avoidance. Drug Safety 9: 441-449.
12. Elman GL (1979) Tissue sulphydryl groups. Arch. Biochem. Biophys. 95: 351-358.
13. Friis H, Andreasen PB (1992) Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987. J. Int. Med. 232: 133-138.
14. Fuchs S, Simon Z, Brezis M (1994) Fatal hepatic failure associated with ciprofloxacin. Lancet 343: 738-739.
15. George DK, Crawford DH (1996) Antibacterial-induced hepatotoxicity. Incidence, prevention and management. Drug Safety 15: 79-85.
16. Grassmick BK, Lehr VT, Sundareson AS (1992) Fulminant hepatic failure possibly related to ciprofloxacin. Ann. Pharmacother. 26: 636-369.
17. Hunt CM, Yuen NA, Stirnadel-Farrant HA, Suzuki A (2014) Age-related differences in reporting of drug-associated liver injury: data-mining of WHO Safety Report Database. Regul. Toxicol. Pharmacol. 70: 519-526.
18. Kitson TM, Kitson KE (2000) The effect of quercetin, a widely distributed flavonoid in food and drink, on cytosolic aldehyde dehydrogenase: a comparison with the effect of diethylstilboestrol. Biochim. Biophys. Acta 1481: 247-254.
19. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, Brodie BB (1973) Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187: 211-217.
20. Nordmann P, Pechinot A, Kazmierczak A (1981) Cytotoxicity and uptake of perfloxacin, ciprofloxacin and ofloxacin in primary culture of rat hepatocytes. J. Antimicrob. Chemother. 24: 355-365.
21. Nori S, Nebesio C, Brashear R, Travers JB (2004) Moxifloxacin associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Arch. Dermatol. 140: 1537-1538.
22. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70: 158-169.
23. Parks DA, Granger DN (1988) Ischemia-reperfusion injury: a radical view. Hepatology 8: 680-682.
24. Sahna E, Parlakpinar H, Cihan OF, Turkoz Y, Acet A (2006) Effects of aminoguanidine against renal ischaemia-reperfusion injury in rats. Cell. Biochem. Funct. 24: 137-141.
25. Spahr L, Rubbia-Brandt L, Marinescu O (2001) Acute fatal hepatitis related to levofloxacin. J. Hepatol. 35: 308-309.
26. Tieppo J, Cuevas MJ, Vercelino R, Tuñón MJ, Marroni NP, González-Gallego J (2009) Quercetin administration ameliorates pulmonary complications of cirrhosis in rats. J. Nutr. 139: 1339-1346.
27. Uchiyama M, Mihara M (1978) Determination of MDA precursor in tissue by TBA test. Anal. Biochem. 36: 271-278.
28. Weyers AI, Ugnia LI, Ovando HG, Gorla NB (2002) Ciprofloxacin increases hepatic and renal lipid hydroperoxides levels in mice. Biocell 26: 225-228.
29. Weyers A, Ugnia LI, Ovando HG, Gorla NB (2008) Antioxidant capacity of vitamin C in mouse liver and kidney tissues. Biocell 32: 27-31.
30. Zhao MH, Jiang ZT, Liu T, Li R (2014) Flavonoids in Juglans regia L. leaves and evaluation of in vitro antioxidant activity via intracellular and chemical methods. Sci. World J. 2014: 303878.
31. Zimpfer A, Propst A, Mikuz G, Vogel W, Terracciano L, Stadlmann S (2004) Ciprofloxacin-induced acute liver injury: case report and review of literature. Virchows Arch. 444: 87-89.